Lihua Julie Zhu

North China University of Science and Technology

Full Professor(heuristic)

CRISPR and Genetic Engineering · Molecular Biology

h-index66

i10-index143

Publications335

Citations16,052

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 59

Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease
Science Advances · 2026-04-24
Supplementary Figure 4 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Table S1 and Table S2 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Supplementary Figure 5 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Supplementary Figure 3 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Data from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Supplementary Figure 2 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
Supplementary Figure 1 from p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy
2026-03-02
The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis
Medicine · 2026-01-02
Sequential ultrasound and ultra-high pressure co-treatment improves the structural and functional properties of sheep skin protein hydrolysates and their performance in low-pH beverage systems
Food Research International · 2026-01-02
Machine learning prognosis model for locally recurrent rectal cancer patients after radioactive 125I seed implantation
Scientific Reports · 2025-12-17
FcγRIIa in autoimmunity: Unraveling pathogenic mechanisms and therapeutic opportunities
Autoimmunity Reviews · 2025-12-08
Supplementary Figure S4 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Figure S8 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Figure S6 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Figure S7 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Figure S1 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Figure S2 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Supplementary Table S2 from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14
Data from MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer
2025-11-14

Open author page on OpenAlex →